Moderna, Merck cancer vaccine combo cuts melanoma recurrence by 44%

Moderna's shares rose over 8% in premarket trading on Tuesday after the data, which the companies hailed as spectacular. Merck's shares were up nearly 2% at $111.12.

Related Keywords

New York ,United States ,Memorial Sloan Kettering Cancer Center ,Merck Moderna ,Paul Burton ,Merck Keytruda ,Roche Tecentriq ,Eliav Barr ,Mary Lenora Disis ,Gritstone Bio Inc ,Moderna Inc ,Uw Medicine Cancer Vaccine Institute In Seattle ,Merck Co ,Bristol Myers Squibb ,Bio Inc ,Cancer Vaccine Institute ,